Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters

Overview of attention for article published in Radiation Oncology, October 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 11,352 followers.

RT @CZamboglou: Here is our new paper on ex vivo RT of prostate cancer specimen. ➡️significant differences in intrinsic radio resistance be…

08 Oct 2022

Reply Repost Favourite

RT @CZamboglou: Here is our new paper on ex vivo RT of prostate cancer specimen. ➡️significant differences in intrinsic radio resistance be…

07 Oct 2022

Reply Repost Favourite

Give it a read..👇👇👇👇

07 Oct 2022

Reply Repost Favourite

Here is our new paper on ex vivo RT of prostate cancer specimen. ➡️significant differences in intrinsic radio resistance between lesions. ➡️basic PSMA PET/MRI parameters might distinguish radio resistant from sensitive lesions. https://t.co/DDVIn36Ci0

07 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.